Hagop Youssoufian - Net Worth and Insider Trading

Hagop Youssoufian Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hagop Youssoufian owns 3 companies in total, including DNIB Unwind Inc (BINDQ) , Progenics Pharmaceuticals Inc (PGNX) , and Alaunos Therapeutics Inc (TCRT) .

Click here to see the complete history of Hagop Youssoufian’s form 4 insider trades.

Insider Ownership Summary of Hagop Youssoufian

Ticker	Comapny	Transaction Date	Type of Owner
BINDQ	DNIB Unwind Inc	2015-03-07	CHIEF MEDICAL OFFICER
PGNX	Progenics Pharmaceuticals Inc	2014-03-03	Executive Vice President R&D
TCRT	Alaunos Therapeutics Inc	2011-07-15	Executive VP & CMO

Hagop Youssoufian Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hagop Youssoufian Ownership Network

Ownership Network List of Hagop Youssoufian

No Data

Ownership Network Relation of Hagop Youssoufian

Hagop Youssoufian Owned Company Details

What does DNIB Unwind Inc do?

Who are the key executives at DNIB Unwind Inc?

Hagop Youssoufian is the CHIEF MEDICAL OFFICER of DNIB Unwind Inc. Other key executives at DNIB Unwind Inc include director & other: Chairman Daniel Lynch , Chief Scientific Officer Jonathan Michael Yingling , and director & PRESIDENT & CEO Andrew Hirsch .

DNIB Unwind Inc (BINDQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DNIB Unwind Inc (BINDQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DNIB Unwind Inc (BINDQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DNIB Unwind Inc (BINDQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

DNIB Unwind Inc Insider Transactions

No Available Data

What does Progenics Pharmaceuticals Inc do?

Who are the key executives at Progenics Pharmaceuticals Inc?

Hagop Youssoufian is the Executive Vice President R&D of Progenics Pharmaceuticals Inc. Other key executives at Progenics Pharmaceuticals Inc include Chief Medical Officer Asha Das , 10 percent owner & other: See Explanation of Responses Balaji Venkataraman , and 10 percent owner & other: See Explanation of Responses Virinder Nohria .

Progenics Pharmaceuticals Inc (PGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Progenics Pharmaceuticals Inc (PGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Progenics Pharmaceuticals Inc (PGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Progenics Pharmaceuticals Inc (PGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Progenics Pharmaceuticals Inc Insider Transactions

No Available Data

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

Hagop Youssoufian is the Executive VP & CMO of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, Hagop Youssoufian made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alaunos Therapeutics Inc Insider Transactions

No Available Data

Hagop Youssoufian Mailing Address

Above is the net worth, insider trading, and ownership report for Hagop Youssoufian. You might contact Hagop Youssoufian via mailing address: Navy Yard Plaza, One First Avenue, Parris Building #34, Boston Ma 02129.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.